Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avastin in First Line Metastatic or Recurrent Breast Cancer. Retrospective Phase IV Study

NCT01215123 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01215123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01215123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avastin in First Line Metastatic or Recurrent Breast Cancer. Retrospective Phase IV Study
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2012
Enrollment
28 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer